| Identification | Back Directory | [Name]
methiodal sodium | [CAS]
126-31-8 | [Synonyms]
Segosin
Skiodan
Abrodan
Abroden
Conturex
Methiodal
Kontrast-u
Diagnorenol
Radiographol
Sodium methiodal.
Iodomethanesulfonic acid, sodium salt
Methanesulfonic acid, iodo-, sodium salt
Methanesulfonic acid, 1-iodo-, sodium salt (1:1) | [EINECS(EC#)]
204-782-6 | [Molecular Formula]
CH2IO3S.Na | [MDL Number]
MFCD00867918 | [MOL File]
126-31-8.mol | [Molecular Weight]
243.98 |
| Chemical Properties | Back Directory | [Appearance]
A white, crystalline powder; odorless;
slight salty taste followed by sweetish aftertaste.
Decomposes on exposure to light, solutions are
neutral to litmus. Soluble in water; very soluble
in methanol; slightly soluble in alcohol; practically
insoluble in | [Uses]
Radiopaque contrast medium.
| [CAS DataBase Reference]
126-31-8 | [EPA Substance Registry System]
Sodium iodomethanesulfonate (126-31-8) |
| Hazard Information | Back Directory | [Chemical Properties]
A white, crystalline powder; odorless;
slight salty taste followed by sweetish aftertaste.
Decomposes on exposure to light, solutions are
neutral to litmus. Soluble in water; very soluble
in methanol; slightly soluble in alcohol; practically
insoluble in | [General Description]
Colorless crystals. | [Air & Water Reactions]
Water soluble. | [Reactivity Profile]
Sensitive to light. | [Health Hazard]
ACUTE/CHRONIC HAZARDS: Toxic. | [Brand name]
Abrodil;Myelotrast;Neo-sombraven;Sergozin;Skiodan sodium;Urombal. | [World Health Organization (WHO)]
Methiodal sodium, a radio-opaque medium, was formerly used for
the examination of the urinary tract. Its use was associated with muscle spasms
presumed to result from irritation of motor nerve roots in the spinal canal. This led
to its withdrawal in Sweden in 1975 when a safer alternative became available.
Preparations containing methiodal sodium were subsequently withdrawn
worldwide by the manufacturer. |
|
|